Ding, Li-Yun
Hou, Ya-Chin
Kuo, I-Ying
Hsu, Ting-Yi
Tsai, Tsung-Ching
Chang, Hsiu-Wei
Hsu, Wei-Yu
Tsao, Chih-Chieh
Tian, Chung-Chen
Wang, Po-Shun
Wang, Hao-Chen
Lee, Chung-Ta
Wang, Yi-Ching
Lin, Sheng-Hsiang
Hughes, Michael W.
Chuang, Woei-Jer
Lu, Pei-Jung
Shan, Yan-Shen
Huang, Po-Hsien https://orcid.org/0000-0002-2997-5181
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (MOST 105-2320-B-006-018-MY3)
Article History
Received: 17 January 2020
Accepted: 31 May 2020
First Online: 17 June 2020
Ethics approval and consent to participate
: Patient PDA samples collected upon surgical resection, and the usage of tumor specimen for research, with individuals who underwent surgical resection signed informed consent before surgery, was approved and is legally covered by local ethics committee. The usage of these tissues for tissue microarray (TMA) manufacturing was approved (A-ER-105-459) and has been published [], including the usage of clinical information from all PDA patients between 2001 and 2012 reviewed using electronic medical records, the TMAs constructed from FFPE blocks of 86 archived PDA specimens. All experimental procedures using live animals were conducted in accordance with protocols approved by local ethics and animal care and usage committee (IACUC#105244).
: The authors declare that they have no competing interest.